ML
ALXN

McAdam LLC’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

McAdam LLC’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17
Closed -$2K – 691
2018
Q3 		$2K Hold
17
– – ﹤0.01% 548
2018
Q2 		$2K Sell
17
-17
-50% -$2K ﹤0.01% 520
2018
Q1 		$4K Buy
+34
New +$4K ﹤0.01% 449